Merck

[Not Yet Scheduled]
Merck has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs. Our scientific advances have made a difference in the lives of millions of patients worldwide. From Merck’s development of the first measles and mumps vaccines to treatments for cancer, diabetes and infectious diseases, we are an industry leader in bringing forth innovative new medicines. We operate in more than 140 countries and had sales of more than $48 billion in 2021.
We recognize that building partnerships is one of our most important jobs. In 2021, over 65% of our human health revenue was attributable to acquisitions, alliance partnerships and patents and our team executed more than 90 significant business development transactions. We believe that by working together we can play a major role in transforming global health care. Together we can invent for life. Learn more at www.merck.com/licensing.
Ticker:
MRK
Exchange:
NYSE
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
New Jersey
Company HQ Country:
United States
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
Large, diverse pipeline from discovery through commercial
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided